View Agent
| Agent Info | |
| Agent: | matuzumab |
| Synonyms: | EMD-62000;EMD-72000;Anti-EGF receptor humanized antibody (iv, cancer), Merck KGaA/ Takeda Pharmaceuticals;Anti-EGFR humanized mAb (iv, cancer), Merck KGaA/ Takeda Pharmaceuticals;Anti-epidermal growth factor receptor humanized antibody (iv, cancer), Merck KGaA/ Takeda Pharmaceuticals |
| Drug Status For Certain Diseases: | gastric cancer(phase II) |
| Classification: | a humanized anti-EGFR monoclonal antibody |
| Target: | Epidermal growth factor receptor |
| KEGG Pathway: | NA |
| Wiki Pathway: | ErbB Signaling Pathway Integrated Breast Cancer Pathway miR-targeted genes in epithelium - TarBase Signaling by ERBB2 miR-targeted genes in muscle cell - TarBase Focal Adhesion Arylhydrocarbon receptor (AhR) signaling pathway miR-targeted genes in lymphocytes - TarBase L1CAM interactions Aryl Hydrocarbon Receptor Pathway TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer Signaling by EGFR Hair Follicle Development Gastrin-CREB signalling pathway via PKC and MAPK PIP3 activates AKT signaling AGE/RAGE pathway EGF/EGFR Signaling Pathway Hair Follicle Development Bladder Cancer Signaling by ERBB4 Aryl Hydrocarbon Receptor Regulation of Actin Cytoskeleton Spinal Cord Injury MAPK Signaling Pathway Extracellular vesicle-mediated signaling in recipient cells Nanoparticle-mediated activation of receptor signaling Integrated Pancreatic Cancer Pathway Signaling Pathways in Glioblastoma Gastric cancer network 2 |